← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Medical Officer Konstantinos Xynos sold $80K of Replimune Group, Inc.

Sold$79,858
$10.92Price
7,313Shares
−6%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Thu, Nov 16. Filed Fri, Nov 17, 8:01 PM ET, after the close. Not investment advice.